41 results
424B5
awfr5fiud1xqruevedtv
24 Mar 22
Prospectus supplement for primary offering
8:02pm
424B5
tlhu2ito58dng3
23 Mar 22
Prospectus supplement for primary offering
5:14pm
424B5
1czda3g pza32e
17 Nov 21
Prospectus supplement for primary offering
9:02am
424B5
wtkm12r4upmeqni0
15 Nov 21
Prospectus supplement for primary offering
5:24pm
8-K
EX-99.1
nuun8kfo7
27 Oct 20
Sobi obtains global co-development and exclusive ex-U.S. commercialization rights for systemic pegcetacoplan, a targeted C3 therapy
7:17am
8-K
umamsav4rpbuin2ow5zn
6 Apr 20
Departure of Directors or Certain Officers
8:30am
S-8
EX-99.1
37g4j0iu zk6rdtih2
27 Feb 20
Registration of securities for employees
12:00am